Publications
- Ruthenium(II) Complex Containing a Redox-Active Semiquinonate Ligand as a Potential Chemotherapeutic Agent: From Synthesis to In Vivo Studies2020 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- pH-responsive polymersome-mediated delivery of doxorubicin into tumor sites enhances the therapeutic efficacy and reduces cardiotoxic effects2021 | First Faculty of Medicine
- Enhanced Antitumor Efficacy through an "AND gate" Reactive Oxygen-Species-Dependent pH-Responsive Nanomedicine Approach2021 | First Faculty of Medicine
- Reactive Oxygen Species (ROS)-Responsive Polymersomes with Site-Specific Chemotherapeutic Delivery into Tumors via Spacer Design Chemistry2020 | First Faculty of Medicine
- In vitro evaluation of the monoclonal antibody Cu-64-IgG M75 against human carbonic anhydrase IX and its in vivo imaging2018 | First Faculty of Medicine, Faculty of Science, Faculty of Pharmacy in Hradec Králové
- Biopolymer strategy for the treatment of Wilson's disease2018 | First Faculty of Medicine
- Poly(ethylene oxide monomethyl ether)-block-poly(propylene succinate) Nanoparticles: Synthesis and Characterization, Enzymatic and Cellular Degradation, Micellar Solubilization of Paclitaxel, and in Vitro and in Vivo Evaluation2018 | First Faculty of Medicine
- Poly(2-ethyl-2-oxazoline) conjugates with doxorubicin for cancer therapy: In vitro and in vivo evaluation and direct comparison to poly[N-(2-hydroxypropyl)methacrylamide] analogues2017 | First Faculty of Medicine
- Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL42017 | First Faculty of Medicine
- Chelating polymeric beads as potential therapeutics for Wilson's disease2014 | First Faculty of Medicine
Loading network view...